PERSPECTA

News from every angle

← Back to headlines

Samsung Biologics Launches Takeover Bid for Biotech Firm PolyPeptide

Samsung Biologics has published a prospectus for a public tender offer to acquire Danish biotechnology company PolyPeptide Group, with the formal takeover bid expected to launch in September. The move expands Samsung's capabilities in peptide synthesis and contract manufacturing services.

31 Aug, 08:57 — 31 Aug, 08:57
PostShare

Sources

Showing 1 of 3 sources
gdn-online2d ago

Health: Samsung Biologics to launch takeover bid for PolyPeptide in September - Gulf Daily News (Bahrain)

Health: Samsung Biologics to launch takeover bid for PolyPeptide in September  Gulf Daily News (Bahrain)

Read full article →

Coverage Timeline

First report: taiwan-news · 31 Aug, 05:00Full coverage: 3 · 4hWindow: 4h
Left-leaningCenterRight-leaning
taiwan-news31 Aug, 05:00First to report

Samsung Biologics publishes prospectus for PolyPeptide public tender offer - Taiwan News

morningstar31 Aug, 05:35

Samsung Biologics publishes prospectus for PolyPeptide public tender offer - Morningstar

3h later
gdn-online31 Aug, 08:57Latest update

Health: Samsung Biologics to launch takeover bid for PolyPeptide in September - Gulf Daily News (Bahrain)

Related Stories

Honda Orders $9 Billion Supplier Cost Cuts to Counter Chinese EV Rivals

36m ago

US-Iran Conflict Intensifies with Retaliatory Strikes and Rising Energy Prices

39m ago

Apple Appoints John Ternus as CEO Amid Leadership Transition and Strategic Shift

41m ago

Nestlé to Sell Vitamins Business to Financial Investor for $1 Billion

56m ago